ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Pharmacist Impact on Vaccinations Rates in Cardiothoracic Transplant Recipients

K. Zaborowski, J. Dedering, R. Felkner

William S. Middleton Memorial Veterans Hospital, Madison, WI

Meeting: 2019 American Transplant Congress

Abstract number: D22

Keywords: Heart transplant patients, Lung transplantation, Vaccination

Session Information

Date: Tuesday, June 4, 2019

Session Name: Poster Session D: Quality Assurance Process Improvement & Regulatory Issues

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Impact of a Pharmacist-Led Vaccine Recommendation Program for Pediatric Kidney Transplant Candidates.
  • Improving Vaccination Rates for Lung Transplant Candidates.

*Purpose: The purpose of this project is to determine the impact pharmacists have on cardiothoracic transplant recipients’ vaccination status at the time of transplant surgery.

*Methods: A retrospective cohort analysis at a single institution was completed to assess vaccination status at the time of transplant and documented vaccines received within one year post transplant. All patients who received a heart or lung transplant at the institution between January 2008 and January 2011 before pharmacist involvement were compared to patients transplanted between January 2014 and January 2017 after pharmacist involvement. The primary outcome of the project is the change in vaccination rate at the time of transplant following implementation of a pharmacist into a cardiothoracic transplant clinic. Secondary outcomes include: the number of recipients fully vaccinated at the time of transplant, the change in vaccination rate for each individual vaccination, the difference in readmissions for preventable infectious diseases 12 months post-transplant. Comparisons were analyzed using Chi-squared or Fisher’s exact test.

*Results: The vaccination rate in the control group was 2.67 per person compared to 6.54 per person in the intervention group resulting a positive percent change of 145 percent (p-value: <0.0001). Thirty percent of patients were fully vaccinated at time of transplant in the intervention group compared to zero percent in the control group (p-value: <0.001). The percent of patients re-admitted within 12 months for a vaccine preventable disease did not differ significantly between the control and intervention group (13% vs. 10% respectively; p-value: >0.05).

*Conclusions: Pharmacist involvement pre-transplant improved vaccination rates and increased the number of patients fully vaccinated at time of transplant.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Zaborowski K, Dedering J, Felkner R. Pharmacist Impact on Vaccinations Rates in Cardiothoracic Transplant Recipients [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/pharmacist-impact-on-vaccinations-rates-in-cardiothoracic-transplant-recipients/. Accessed February 27, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.